
AGS THERAPEUTICS
MABDESIGN MEMBER
About us
We are an innovative and fast growing preclinical stage biotech-pharma.
Know-how
EVs, microalgae, therapeutics, vaccines, mRNA
Business offer
We develop extracellular vesicles from microalgae (MEV) as delivery systems of innovative molecules (mRNA, siRNA, proteins...) for human therapeutics and vaccines. We also develop a manufacturing capacity of MEVs to supply biological materials in support to preclinical and clinical studies.
Field of application
- antibodies
- immunomodulators
Therapeutic application
- genetic diseases
- infectiology
- immunology
- oncology
- ophtalmology
Expertise
- Screening & Identification
- Therapeutic libraries
- In silico
- In-vivo models
- In-vitro & ex-vivo models
- Pharmacology & Biological activity
- PK/PD bioavailability
- Mode of Action
- Therapeutic efficacy
Category
- Therapeutic product
- Service
Contact
- Manuel Vega
CEO - 10 Rue Greneta 75003 Paris
- 0777046096
- mv@ags-tx.com
- https://www.ags-tx.com/